F-star Therapeutics, Inc. Common Stock

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -44.44% and 0.32%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: BNGO, FSTX.

February couldn't continue the streak that was started in January. In February, I had five transactions. Check out the companies I will look into next month.

Related tickers: ABBV, AHH, AJRD, ATVI, AVGO, BAM, BN, BRAG, CBOE, CVS, DGRO, ENB, ENBA, FSTX, IBKR, ICE, INTC, LHX, LMT, MS, MSFT, NDAQ, NGMS, NTST, PFH, PRH, PRS, PRU, RELY, STNE, TJX, UDMY, V, VICI.